Citi Pharma Limited has approved the initial public offering (IPO) of its wholly owned subsidiary, Citi Veterinary Pharma ...

Citi Pharma Limited has received approval from the Securities and Exchange Commission of Pakistan to reserve the name for its proposed REIT management ...

New instructional spot featuring Rio Rocket highlights a simple transition process for customers bringing their own ...

Squanch Games' sequel to their comedic sci-fi adventure High on Life is here and it's almost everything I wanted for a sequel. High on Life 2 delivers on upping the ante with new guns, enemies, a kick ...

PMMI, The Association for Packaging and Processing Technologies, has released a new infographic previewing its upcoming white paper, 2025 Trends and Challenges in Pharmaceutical Manufacturing. The ...

Americans pay about three times what other wealthy nations do for branded prescription drugs. For years, policymakers have tried to fix this by cutting U.S. drug prices directly. President Trump has ...

India-based Sun Pharmaceutical Industries Ltd is reportedly evaluating a potential acquisition of Organon & Co (NYSE: OGN), a U.S.-based women's healthcare company. If it goes through, the deal that ...

With a lioness-themed rebrand tied to its latest buy, Athira Pharma is roaring into the new year under its second new moniker. The Seattle-based biopharma has chosen LeonaBio as its new name, and will ...

After months of threats, President Trump eased up pressure on drugmakers late last year. That’s all it took for investors to notice that the beaten-down sector was actually growing just fine. Talk of ...

Nivagen operates an aseptic manufacturing facility in Sacramento, California, designed to support the production of IV bags, vials, prefilled syringes, and cartridges Nivagen was founded in 2009 PAI ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A South Carolina pharmaceutical ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.